Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone and Diazoxide for HAAF Prevention
NCT03608163Phase 4Terminated
- Sponsor
- Albert Einstein College of Medicine
- Start
- Jan 2019
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
A Phase 4 trial of naloxone in Hypoglycemia unawareness (HU), type 1 diabetes mellitus (T1D), sponsored by Albert Einstein College of Medicine. Started Jan 2019; status: terminated.
02
Drugs
naloxone
03
Conditions
Hypoglycemia unawareness (HU)type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03608163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03608163.